CompletedNCT00759473
D-cycloserine or placebo to reduce cocaine-cue craving
About this title
Read the official source — NCT00759473Medication studyAges 18–65United StatesMental health
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Charleston and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateSeptember 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 79
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00759473
- Official title
Show the full official title
D-Cycloserine Facilitation of Cocaine - Cue Extinction
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedCharleston · Pickens
Questions about this study
Who is behind this study?
The study sponsor is Medical University of South Carolina, a university.
Did this study involve medication?
Yes. The study involved medication, including D-Cycloserine (DCS) and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to explore more studies?
Explore studiesRelated studies
A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation
Buprenorphine and naloxone for heroin dependence